GABAA and μ-opioid receptor binding in the globus pallidus and entopeduncular nucleus of animals symptomatic for and recovered from experimental parkinsonism

Brain Research

Volumn 947, Issue 2, 2002, Pages 284-289

  Schroeder, Joseph A ^a   Schneider, Jay S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Opioid receptor; Autoradiography; Entopeduncular nucleus; GABAA; Globus pallidus; MPTP

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 AMINOBUTYRIC ACID A RECEPTOR; ENKEPHALIN; MU OPIATE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAT; CONTROLLED STUDY; CONVALESCENCE; CORRELATION ANALYSIS; ENTOPEDUNCULAR NUCLEUS; GLOBUS PALLIDUS; MOTOR DYSFUNCTION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN SECRETION; RECEPTOR BINDING; SYMPTOM;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; AUTORADIOGRAPHY; CATS; ENTOPEDUNCULAR NUCLEUS; GLOBUS PALLIDUS; MALE; PARKINSONIAN DISORDERS; RECEPTORS, GABA-A; RECEPTORS, OPIOID, MU;

EID: 0037199772     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03010-X     Document Type: Article

References (36)

1. Evidence for presynaptic localization of opiate binding sites on striatal efferent fibers
2. The functional anatomy of basal ganglia circuits: Neural substrates of parallel processing
3. Quantitative in situ hybridization evidence for differential regulation of preproenkephalin and dopamine D2 receptor mRNA levels in the rat striatum: Effects of unilateral intrastriatal injections of 6-hydroxydopamine
4. 3H-5HT from slices of rat globus pallidus
5. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism
6. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism
7. 3H]-flunitrazepam
8. Changes in benzodiazepine and acetylcholine receptors in the globus pallidus in Parkinson's disease
9. Preproenkephalin mRNA and methionine-enkephalin increase in mouse striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment
10. Alterations in cortical and basal ganglia levels of opioid receptor binding an a rat model of l-DOPA induced dyskinesia
11. On the role of enkephalin cotransmission in the GABA-ergic striatal efferents to the globus pallidus
12. Proenkephalin mRNA levels in rat striatum are increased and decreased, respectively, by selective D2 and D1 dopamine receptor antagonists
13. Dopaminergic neurons of the substantia nigra modulate preproenkephalin A gene expression in rat striatal neurons
14. Presynaptic versus postsynaptic localization of μ and δ opioid receptors in dorsal and ventral striatopallidal pathways
15. Characterization of benzodiazepine receptor changes in substantia nigra, globus pallidus and entopeduncular nucleus after striatal lesions
16. D2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons
17. 3H]-flunitrazepam autoradiography
18. Further investigations into the pathophysiology of MPTP-induced parkinsonism in the primate: An intracerebral microdialysis study of gamma-aminobutyric acid in the lateral segment of the globus pallidus
19. Alterations in pallidal neuronal responses to peripheral sensory and striatal stimulation in symptomatic and recovered parkinsonian cats
20. Autoradiographic mapping of μ-opioid receptor changes in rat brain after long-term haloperidol treatment: Relationship to the development of vacuous chewing movements
21. Neurochemical evaluation of the striatum in symptomatic and recovered MPTP-treated cats
22. Production of a parkinsonian-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): Behavior, histology and biochemistry
23. Striatal preproenkephalin gene expression is upregulated in acute but not chronic parkinsonian monkeys: Implications for the contribution of the indirect striatopallidal circuit to parkinsonian symptomatology
24. Striatal enkephalin gene expression does not reflect parkinsonian signs
25. Alterations in expression of messenger RNAs encoding two isoforms of glutamic acid decarboxylase in the globus pallidus and entopeduncular nucleus in animals symptomatic for and recovered from experimental parkinsonism
26. A receptor density
27. Gamma-aminobutyric acid release in the globus pallidus in vivo after a 6-hydroxydopamine lesion in the substantia nigra of the rat
28. Parallel increases in striatal glutamic acid decarboxylase activity and mRNA levels in rats with nigrostriatal pathway lesions
29. Discrete mapping of brain mu and delta opioid receptors using selective peptides: Quantitative autoradiography, species differences and comparison with kappa receptors
30. Glutamate decarboxylase (GAD67 and GAD65) gene expression is increased in a subpopulation of neurons in the putamen of parkinsonian monkeys
31. A IPSCs in the rat globus pallidus in vitro
32. Striatal met-enkephalin concentration increases following nigrostriatal denervation
33. Similar time course changes in striatal levels of glutamic acid decarboxylase and preproenkephalin mRNA following dopaminergic deafferentiation in the rat
34. Increase of enkephalin and decrease of substance P immunoreactivity in the striatum of the rat after midbrain 6-hydroxydopamine lesions
35. Neutral endopeptidase-24.11, mu and delta opioid receptors after selective brain lesions: An autoradiographic study